Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos (t) ide analogue‐induced hepatitis B surface antigen loss

TCF Yip, VWS Wong, YK Tse, LY Liang… - Alimentary …, 2021 - Wiley Online Library
Background It is unknown whether patients with chronic hepatitis B (CHB) who achieved
hepatitis B surface antigen (HBsAg) seroclearance spontaneously or following anti‐viral …
被引用次数：28 相关文章

Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos (t) ide analogue-induced hepatitis B surface antigen loss.

TC Yip, VW Wong, YK Tse, LY Liang… - Alimentary …, 2020 - europepmc.org
Background It is unknown whether patients with chronic hepatitis B (CHB) who achieved
hepatitis B surface antigen (HBsAg) seroclearance spontaneously or following anti-viral …

Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos (t) ide analogue-induced hepatitis B surface antigen loss.

TCF Yip, VWS Wong, YK Tse, LY Liang, VWK Hui… - 2020 - cabidigitallibrary.org
Background: It is unknown whether patients with chronic hepatitis B (CHB) who achieved
hepatitis B surface antigen (HBsAg) seroclearance spontaneously or following anti-viral …

Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos (t) ide analogue-induced hepatitis B surface antigen loss

TC Yip, VW Wong, YK Tse, LY Liang, VW Hui… - Alimentary …, 2021 - hero.epa.gov
BACKGROUND: It is unknown whether patients with chronic hepatitis B (CHB) who
achieved hepatitis B surface antigen (HBsAg) seroclearance spontaneously or following anti …

Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos (t) ide analogue‐induced hepatitis B surface antigen loss

TCF Yip, VWS Wong, YK Tse, LY Liang… - Alimentary …, 2020 - infona.pl
Background It is unknown whether patients with chronic hepatitis B (CHB) who achieved
hepatitis B surface antigen (HBsAg) seroclearance spontaneously or following anti‐viral …

Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos (t) ide analogue-induced hepatitis B surface antigen loss

TCF Yip, VWS Wong, YK Tse… - Alimentary …, 2021 - pubmed.ncbi.nlm.nih.gov
Background It is unknown whether patients with chronic hepatitis B (CHB) who achieved
hepatitis B surface antigen (HBsAg) seroclearance spontaneously or following anti-viral …

Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos (t) ide analogue‐induced hepatitis B surface antigen loss

TCF Yip, VWS Wong, YK Tse, LY Liang… - Alimentary …, 2020 - cir.nii.ac.jp
抄録< jats: title> Summary</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats:
p> It is unknown whether patients with chronic hepatitis B (CHB) who achieved hepatitis B …